Nodenza Venture Partners to attend BIO CEO & Investor Conference 2024
New York, February 5, 2024 – Nodenza Ventures Partners (“Nodenza”) will attend the BIO CEO & Investor Conference in New York on 10-11 February 2024. To find out more about how we can partner with you to create, advise, and help grow your company, please reach out to us to schedule a meeting.
Contacts:
Nodenza Venture Partners
Nodenza Info
Mo Advisory PR
Mo Noonan / Jonathan Birt
mo@mopradvisory.com
Notes to Editors
About Nodenza Venture Partners
Nodenza Venture Partners invests globally in early-stage and pre-commercial companies and products designed to bring exceptional patient benefit. Our bi-modal investment strategy combines early-stage opportunities – advancing new treatment modalities through active IND to phase 2 - with pre-commercial targets supporting their transition from scientific to commercial companies delivering strong upside potential. Established by a team of experienced life sciences entrepreneurs, founders and leaders, our approach leverages Nodenza’s extensive expertise in the creation and growth of new companies, as well as late-stage product development and launch.